PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹559 Cr | ₹559 Cr | ₹460 Cr | ₹661 Cr | ₹625 Cr |
What is the latest Revenue of PANACEA BIOTEC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹559 Cr |
| Mar2024 | ₹559 Cr |
| Mar2023 | ₹460 Cr |
| Mar2022 | ₹661 Cr |
| Mar2021 | ₹625 Cr |
How is Revenue of PANACEA BIOTEC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹559 Cr | -0.01 | |
| Mar2024 | ₹559 Cr | 21.57 | |
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | - | |
Compare Revenue of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,232.5 Cr | -7.1% | 2.1% | -17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -7.1% |
2.1% |
-17.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses